Cost effectiveness of imiquimod 5% cream compared with methyl aminolevulinate-based photodynamic therapy in the treatment of non-hyperkeratotic, non-hypertrophic actinic (solar) keratoses: a decision tree model.
about
Network meta-analysis of the outcome 'participant complete clearance' in nonimmunosuppressed participants of eight interventions for actinic keratosis: a follow-up on a Cochrane review.Pharmacotherapy of actinic keratosis: an update.A network meta-analysis of the relative efficacy of treatments for actinic keratosis of the face or scalp in EuropeCost-effectiveness of initiating extrafine- or standard size-particle inhaled corticosteroid for asthma in two health-care systems: a retrospective matched cohort study.Cost-utility of first-line actinic keratosis treatments in FinlandImiquimod 3.75% cream (Zyclara) for the treatment of actinic keratoses.A cost-utility analysis of ingenol mebutate gel for the treatment of actinic keratosis: a Scottish perspective.Pharmacoeconomic Considerations in Treating Actinic Keratosis: An Update.Pharmacoeconomy of drugs used in the treatment of actinic keratoses.British Association of Dermatologists' guidelines for the care of patients with actinic keratosis 2017.Patient-reported health outcomes in patients with non-melanoma skin cancer and actinic keratosis: results from a large-scale observational study analysing effects of diagnoses and disease progression.Cost-effectiveness analysis of 5-fluorouracil 0.5%/salicylic acid 10% in the treatment of actinic keratosis in Spain.
P2860
Q34336675-C1A55B00-7E3C-44C6-B379-9129987BE292Q34378153-5B2AFE9E-F2DC-4548-AEF7-1267C33D38A8Q35180653-64F5C19F-EEE2-4837-83ED-71ED917CA6CDQ35216441-C9CAC9BE-FE61-471F-B7CD-D214D6B5225BQ35666250-D98D6106-6AAC-4837-82B5-AE3040B9227AQ37831354-8D29FA4B-5FDB-4B2C-8032-39CB5DE1F0D4Q38386032-09676D4C-D644-43B5-8B34-E0E92921B349Q38804447-69A0271B-663D-46DE-80CD-B65C1EA41AC2Q47743857-760FF11A-79A2-4E66-B8B7-01A0348AA1A1Q48063272-2EF43DEF-3BA3-4CBE-A5F7-FB62ECFD1485Q49907978-BE455DB7-DC4D-4F14-A3F2-B64F7D0DAED6Q53665050-BC269BBD-C23C-4EDE-B593-E3E504660F29
P2860
Cost effectiveness of imiquimod 5% cream compared with methyl aminolevulinate-based photodynamic therapy in the treatment of non-hyperkeratotic, non-hypertrophic actinic (solar) keratoses: a decision tree model.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cost effectiveness of imiquimo ...... atoses: a decision tree model.
@en
Cost effectiveness of imiquimo ...... atoses: a decision tree model.
@nl
type
label
Cost effectiveness of imiquimo ...... atoses: a decision tree model.
@en
Cost effectiveness of imiquimo ...... atoses: a decision tree model.
@nl
prefLabel
Cost effectiveness of imiquimo ...... atoses: a decision tree model.
@en
Cost effectiveness of imiquimo ...... atoses: a decision tree model.
@nl
P1433
P1476
Cost effectiveness of imiquimo ...... ratoses: a decision tree model
@en
P2093
Edward C F Wilson
P304
P356
10.2165/11538670-000000000-00000
P50
P577
2010-01-01T00:00:00Z
P6179
1026888956